跳至主要内容
临床试验/NCT04020419
NCT04020419终止早期 1 期

Natural Berry Extract Treatment of Hemangiomas

Gayle Gordillo2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2020年12月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
终止
发起方
入组人数
12
试验地点
2
主要终点
Decreased Hemangioma Size

研究概览

简要总结

This is a prospective, randomized, double-blind, placebo-controlled parallel group study evaluating the use of PediaBerry for the treatment of hemangiomas in infants ≤ 4 months of corrected gestation age over a 6-month treatment period. Subjects will be followed to age 18 months. A total of 44 subjects will be PediaBerry group and 22 subjects in the placebo control group.

详细描述

PediaBerry™ is a proprietary blend of powdered berry extracts. Placebo: powdered sugar plus McCormick Color from Nature Food Colors Berry and Sky Blue powdered food color (https://www.mccormick.com/spices-and-flavors/extracts-and-food-colors/food-colors/color-from-nature-assorted-food-color ).

Cream vehicle is mixed with PediaBerry™ or placebo at the time of application.Children will receive once daily topical and oral gavage dosing of PediaBerry or placebo.

The first study visit will take place within 2 weeks of subject recruitment. The subject enrollment, consenting and randomization will occur as study visit #0 and will occur at Riley Children's Hospital or Nationwide Children's Hospital. Data collection will be the same at all study visits starting with study visit #1 until the completion of the study. The first dose of PediaBerry™ or placebo will be administered prior to completion of study visit #1, and will also be given at study visits #2-6. Study visits #2-6 will occur monthly study visits until the subject completes 6 months of treatment.Subjects will be weighed and treatment doses adjusted accordingly. Study visits #7-11 to watch for signs of rebound hemangioma proliferation will occur every other month until age 12 months and then at age 15 and 18 months. Urine samples, photos and caliper measurements will occur at each study visit. Some subjects may have less than 11 study visits depending on the age at the time of subject enrollment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

investigational pharmacy will have access to randomization schemes and will package study drug from bulk supplies. All other study team members and participants are blinded.

入排标准

年龄范围
1 Month 至 19 Weeks(Child)
性别
All
接受健康志愿者

入选标准

  • Children with hemangiomas ≤ 4 months and 2 weeks of corrected gestational age
  • Hemangioma size ≥ 1 cm diameter

排除标准

  • Children with hemangiomas that threaten the life of the child or development of vital structures.
  • Children who are breast feeding and mother is taking beta blocker medication
  • Children with previously treated hemangiomas
  • Congenital hemangiomas - cannot distinguish between rapidly involuting and non-involuting congenital hemangiomas
  • Hemangiomas located in the perineal/diapering area - product will get contaminated or wiped off with diapering
  • Children with food allergies to blueberries or any other kind of berry
  • Legal guardian unable to provide informed consent

研究组 & 干预措施

Pediaberry group

Experimental

PediaBerry™ is a proprietary blend powdered berry extracts

干预措施: PediaBerry (Drug)

Placebo

Placebo Comparator

Placebo: powdered sugar plus McCormick Color from Nature Food Colors Berry and Sky Blue powdered food color (https://www.mccormick.com/spices-and-flavors/extracts-and-food-colors/food-colors/color-from-nature-assorted-food-color ).

干预措施: PediaBerry (Drug)

结局指标

主要结局

Decreased Hemangioma Size

时间窗: 6 month treatment period

Decrease in the size of hemangioma \> 50%

次要结局

  • Decreased urinary micro RNA 126 levels(6 month treatment period)

研究者

发起方
Gayle Gordillo
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Gayle Gordillo

Professor

Indiana University

研究点 (2)

Loading locations...

相似试验